7-Deaza-2'-C-methyladenosine

CAS: 443642-29-3

Ref. 3D-W-202771

Produktinformation

• Name: 7-Deaza-2'-C-methyladenosine
• Synonyme: 7-(2-C-Methyl-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amin, 7-(2-C-Methyl-β-<span class="text-smallcaps">D</span>-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 7-(2-C-methyl-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 7H-Pyrrolo(2,3-d)pyrimidin-4-amine, 7-(2-C-methyl-beta-D-ribofuranosyl)-, 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-(2-C-methyl-β-<span class="text-smallcaps">D</span>-ribofuranosyl)-, Lamevudine, Mk 0608, 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-(2-C-methyl-β-D-ribofuranosyl)-, 7-(2-C-Methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Beschreibung

7-Deaza-2'-C-methyladenosine (7DMA) is an antiviral agent that has shown anti-Hepatitis C virus activity in vitro. 7DMA inhibits the binding of a number of compounds to the viral RNA polymerase and blocks mRNA synthesis, leading to inhibition of viral replication. This drug also binds to the Toll-like receptor 3, which is involved in the immune response against hepatitis. 7DMA has been shown to have a pharmacokinetic profile suitable for use as an antiviral agent. However, it does not show any significant pharmacokinetic properties in vivo and needs further study.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 280.28 g/mol
• Formel: C₁₂H₁₆N₄O₄
• Reinheit: Min. 97.0 Area-%